imuno® is designed by Molecular Biologist, Dr Marco Ruggiero, MD. PhD. Author of peer-reviewed scientific papers on immunotherapy and quantum biology.
imuno® is produced under licence in a pharmaceutical facility which is audited by Medsafe, a division of the Ministry of Health of New Zealand, to both GMP and Pharmacy Standards NZ.
$165.00
imuno® is designed by Molecular Biologist, Dr Marco Ruggiero, MD. PhD. Author of peer-reviewed scientific papers on immunotherapy and quantum biology.
imuno® is produced under licence in a pharmaceutical facility which is audited by Medsafe, a division of the Ministry of Health of New Zealand, to both GMP and Pharmacy Standards NZ.
imuno® is the elegant solution. It is the revolutionary supra-molecular structure that reproduces the self-assembly of cell components. This delivers the combined molecules, at the same time, at the required dose, to their biologic targets, and produces powerful support. Also, the manufacturing process for imuno® is meticulous and time-consuming, and it is not technically possible to get the same result by simply mixing the active ingredients together since the procedure follows a proprietary algorithm based on biologic negentropy.
now save 20% on Imuno with coupon code Autism20 – Limited quantity!
Supplied in a silver decorated white glass jar and sealed inside a protective cardboard box (tamper evident).
Compounding of imuno® under the form of a transdermal delivery system (cream) would increase the spectrum of indications that in addition to those recognized for GcMAF and Rerum would thus comprise dermatologic and rheumatologic conditions where the rebalancing of the immune system is sought after. In addition, since the system that we have previously described significantly increases transdermal delivery, it can be foreseen that imuno® may yield effects at the site of application not too different from those observed with injection. In short, the field of application of imuno® comprises, but it is not limited to, all conditions that have been successfully targeted by GcMAF and Rerum.